We are live on ! Find out more
MEDS

DataMeds AI, Inc. Common Stock

5 hedge funds and large institutions have $1.53M invested in DataMeds AI, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.01% more ownership

Funds ownership: 0%0.01% (+0.01%)

Holders
5
Holders Change
+5
Holders Change %
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
1
Millennium Management
New York
$951K +$743K +4,403 New
HF
2
HRT Financial
New York
$336K +$262K +1,556 New
Citadel Advisors
3
Citadel Advisors
Florida
$129K +$101K +596 New
VFIC
4
Valley Forge Investment Consultants
Pennsylvania
$99.3K +$77.6K +460 New
UBS Group
5
UBS Group
Switzerland
$12.8K +$9.95K +59 New

MEDS Hedge Fund Activity: Q1 2025 in Review

5 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in DataMeds AI, Inc. Common Stock (MEDS) for Q1 2025, worth a combined $1.53M.

Buyers outnumbered sellers: 5 funds opened new MEDS positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $743K.

  • 5 institutional investors held DataMeds AI, Inc. Common Stock (MEDS) as of Q1 2025, up from 0 in Q4 2024.
  • Funds reported $1.53M of DataMeds AI, Inc. Common Stock stock for Q1 2025.
  • 5 funds opened new DataMeds AI, Inc. Common Stock positions in Q1 2025 and 0 closed out, a net change of +5 holders.
  • The largest DataMeds AI, Inc. Common Stock buyer in Q1 2025 was Millennium Management, an estimated $743K added.

Based on aggregated 13F filings for Q1 2025.